S
Soumaya Zlitni
Researcher at Stanford University
Publications - 25
Citations - 900
Soumaya Zlitni is an academic researcher from Stanford University. The author has contributed to research in topics: Biology & Medicine. The author has an hindex of 10, co-authored 19 publications receiving 551 citations. Previous affiliations of Soumaya Zlitni include McMaster University.
Papers
More filters
Journal ArticleDOI
Large-Scale Analyses of Human Microbiomes Reveal Thousands of Small, Novel Genes.
Hila Sberro,Brayon J. Fremin,Soumaya Zlitni,Fredrik Edfors,Nick Greenfield,Michael Snyder,Georgios A. Pavlopoulos,Nikos C. Kyrpides,Ami S. Bhatt +8 more
TL;DR: The study suggests that small proteins are highly abundant and those of the human microbiome, in particular, may perform diverse functions that have not been previously reported.
Journal ArticleDOI
Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection
Aravind Natarajan,Soumaya Zlitni,Erin G. Brooks,Summer E. Vance,Alex Dahlen,Haley Hedlin,Ryan Park,A. Han,Danica T. Schmidtke,Renu Verma,Karen B. Jacobson,Julie Parsonnet,Hector Bonilla,Upinder Singh,Benjamin A. Pinsky,Jason R. Andrews,Prasanna Jagannathan,Ami S. Bhatt +17 more
TL;DR: Chertow et al. as discussed by the authors analyzed the dynamics of fecal RNA shedding up to 10 months after COVID-19 diagnosis in 113 individuals with mild to moderate disease, followed for 10 months post-diagnosis.
Journal ArticleDOI
Chemical genomics in Escherichia coli identifies an inhibitor of bacterial lipoprotein targeting
Ranjana Pathania,Soumaya Zlitni,Courtney A. Barker,Rahul Das,David A. Gerritsma,Julie M. Lebert,Emilia Awuah,Giuseppe Melacini,Fred A Capretta,Eric D. Brown +9 more
TL;DR: It is demonstrated that the targets of well-known antibiotics can be identified as high copy suppressors of chemical lethality and MAC13243, a molecule that belongs to a new chemical class and that has a unique mechanism and promising activity against multidrug-resistant Pseudomonas aeruginosa, is discovered.
Journal ArticleDOI
Mutations in C2orf37, encoding a nucleolar protein, cause hypogonadism, alopecia, diabetes mellitus, mental retardation, and extrapyramidal syndrome.
Anas M. Alazami,Amr Al-Saif,Abdulaziz Alsemari,Saeed Bohlega,Soumaya Zlitni,Fatema Alzahrani,Prashant Bavi,Namik Kaya,Dilek Colak,Hanif Khalak,Andy Baltus,Borut Peterlin,Sumita Danda,Kailash P. Bhatia,Susanne A. Schneider,Nadia Sakati,Christopher A. Walsh,Futwan Al-Mohanna,Brian F. Meyer,Fowzan S. Alkuraya,Fowzan S. Alkuraya +20 more
TL;DR: The gene encodes a nucleolar protein of unknown function, and the cellular phenotype observed in patient lymphoblasts implicates a role for the nucleolus in the pathogenesis of this disease.
Journal ArticleDOI
Metabolic suppression identifies new antibacterial inhibitors under nutrient limitation
TL;DR: It is concluded that metabolite suppression profiling is an effective approach to focus MOA studies on compounds impairing metabolic capabilities and can serve as chemical probes of bacterial physiology and as leads for antibacterial drug development.